Methylglyoxal‐glycated apolipoproteins A‐I and A‐ II are associated with new‐onset diabetes in individuals with prediabetes

Diabetes Obesity and Metabolism 2026

View at publisher
Authors: Chloé Chevalier, Arsênio Rodrigues Oliveira, Matthieu Wargny, Chloé Cloteau, Edith Bigot‐Corbel, Cédric Le May, Samy Hadjadj, Bertrand Cariou, MIKAËL CROYAL
DOI: 10.1111/dom.70493
Cited by: 1
References: 6

Abstract

The authors declare no competing interests. The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1111/dom.70493. The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

Fields of Study & Subjects

Advanced Glycation End Products research Diabetes Cardiovascular Risks and Lipoproteins Peroxisome Proliferator-Activated Receptors

Publication details

Journal / source
Diabetes Obesity and Metabolism
Publisher
Wiley
Volume
28
Issue
4
Pages
3434–3438
Publication date
20 January 2026
Language
EN